fifteen to 20 mg/ml ribavirin administered as a small particle aerosol for 10-18 h per day is currently the regimen generally used to treat experimental or naturally-occurring respiratory syncytial ( rs ) or influenza virus infections in humans .
C0021400
influenza
C0042769
virus infections